| #400 |
Padmaja Yerramilli-Rao |
Novartis Ag |
1 |
| #400 |
Maxim Lobovsky |
Formlabs |
1 |
| #400 |
Joseph Michael Azzarelli |
MIT |
1 |
| #400 |
Andreas Mershin |
MIT |
1 |
| #400 |
Uri Ben-David |
Dana-Farber Cancer Institute |
1 |
| #400 |
Don Straus |
Rapid Micro Biosystems |
1 |
| #400 |
Timm R. Baumeister |
Genentech |
1 |
| #400 |
Guo Ping Wei |
Schering |
1 |
| #400 |
Prashanth Vishwanath |
Modular Genetics |
1 |
| #400 |
John P. Wise |
Lovepop |
1 |
| #400 |
Nadia Brugger |
Merck |
1 |
| #400 |
Jae-Won Hwang |
Google |
1 |
| #400 |
Tatsuya Osaki |
Calsonic Kansei |
1 |
| #400 |
Vincent M. Isabella |
Synlogic Operating Company |
1 |
| #400 |
Joe Adelmann |
Truemotion |
1 |
| #400 |
Bruno Melillo |
Harvard University |
1 |
| #400 |
Karl Clauser |
The Broad Institute |
1 |
| #400 |
Ryan Baker |
Cox Communications |
1 |
| #400 |
Chonghui Zhang |
Novartis Ag |
1 |
| #400 |
James Shanahan |
Syndevrx |
1 |
| #400 |
Jan M. Schnorr |
MIT |
1 |
| #400 |
Evan Hunter Williams |
Neurometrix |
1 |
| #400 |
Michael Eilenberg |
MIT |
1 |
| #400 |
Ganeshsingh A. Thakur |
Northwestern University |
1 |
| #400 |
Barbara Brannetti |
Novartis Ag |
1 |
| #400 |
Laurie B. Schenkel |
Amgen |
1 |
| #400 |
Mark Romanowsky |
E Ink Holdings |
1 |
| #400 |
Robin S. Rose |
Lovepop |
1 |
| #400 |
Yvonne J. Yamanaka |
Kaleido Biosciences |
1 |
| #400 |
Jennifer Hui-Chun Ho |
Beth Israel Deaconess Medical Center |
1 |
| #400 |
Paul Nicholas Whatmough |
NVIDIA |
1 |
| #400 |
Richard E. Olson |
Bristol-Myers Squibb |
1 |
| #400 |
Donghyun Lim |
Kyungpook National University Hospital |
1 |
| #400 |
Jenna McGrath |
Fastcap Systems |
1 |
| #400 |
Adam Standley |
Windgap Medical |
1 |
| #400 |
Akash Jain |
Spero Therapeutics |
1 |
| #400 |
Hua Zhang |
Haiwei Zhlyuan Technology (Shenzhen)Co. |
1 |
| #400 |
William M. Shih |
Dana-Farber Cancer Institute |
1 |
| #400 |
David Brancazio |
MIT |
1 |
| #400 |
Kelly Chen |
The Gillette Company |
1 |
| #400 |
Karl Iagnemma |
Motional Ad |
1 |
| #400 |
Katharina Ribbeck |
MIT |
1 |
| #400 |
Bettina Hein |
— |
1 |
| #400 |
Vincent H. Lee |
GE |
1 |
| #400 |
Jeffrey A. Gelfand |
The General Hospital |
1 |
| #400 |
Alla Pritsker |
Sanofi |
1 |
| #400 |
Chris K. VARMA |
Revolution Medicines |
1 |
| #400 |
John Matthew Truelove |
Bitsight Technologies |
1 |
| #400 |
Hamlin M. Jennings |
E. Khashoggi Industries |
1 |
| #400 |
John H. Walton |
Precision Fabrics Group |
1 |